Bulletin
Investor Alert

Market Extra Archives | Email alerts

Nov. 30, 2020, 2:45 p.m. EST

Why the stock market’s COVID vaccine-inspired rally faces a big test this week

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Dow Jones Industrial Average (DJIA)
  • X
    S&P 500 Index (SPX)
  • X
    Russell 2000 Index (RUT)

or Cancel Already have a watchlist? Log In

By William Watts

It paid to look ahead in November as stock-market investors cheered progress on COVID-19 vaccines by rushing into shares of companies expected to benefit the most from a return to some semblance of normalcy.

The week ahead, however, could test the belief that investors can continue to ignore the present, as COVID-19 cases stage a resurgence, magnifying the human tragedy and threatening to undermine the economy’s rapid recovery from the initial near-shutdown caused by the pandemic earlier this year.

The market’s relentless rally, which saw the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.57% both trade and close for the first time above 30,000 on Tuesday, has more than a whiff of “euphoria” about it, said James McDonald, chief executive James McDonald of hedge fund Hercules Investments, in an interview.

McDonald is bracing for a pullback of 20% — or more — of the S&P 500 index SPX by the time of President-elect Joe Biden’s inauguration on Jan. 20. With that in mind, the analyst naturally recommends holding off on buying equities until after the expected smoke clears.

“Twenty percent just gets [the stock market] back to July numbers,” McDonald said. “I think the situation on the ground is less promising than seen in July. ”

The week ahead could bring a test as investors focus on first-tier economic indicators, including the U.S. Institute for Supply Management’s manufacturing report on Tuesday and its services report on Thursday, McDonald said.

Other key indicators include weekly data on U.S. jobless benefit claims on Thursday, which have shown two consecutive increases in first-time applications for benefits for the first time since July. On Friday, the November jobs report is due from the Labor Department.

Investors will also be sifting through real-time data for clues to activity on the retail front on Black Friday and over the weekend, traditionally the biggest shopping day of the year for Americans. That will offer a test of bullish expectations for spending to remain resilient overall, courtesy of a sharp jump in the savings rate as consumers banked fiscal aid dollars and saw spending opportunities curtailed by the pandemic.

The market, meanwhile, has seen a historic November run accompanied by a recent shift in leadership that has resulted in shares of companies and sectors left behind in the pandemic rally, staging a comeback against the large-capitalization tech and internet-related shares of companies that have benefited from the work-from-home phenomenon.

The more cyclically oriented Dow on Tuesday topped the 30,000 milestone for the first time, with the blue-chip gauge outpacing the broader, large-cap S&P 500 /zigman2/quotes/210599714/realtime SPX -0.72% for the month to date. The Dow ended Friday trade up nearly 13% for the month, versus an 11.3% gain for the S&P 500.

More impressively, the small-cap Russell 2000 /zigman2/quotes/210598147/delayed RUT -1.49% , has put in an almost 21% gain so far this month, outpacing the tech-heavy Nasdaq Composite /zigman2/quotes/210598365/realtime COMP -0.87% , up a not-too-shabby 12%, and the more large-cap tech-concentrated Nasdaq-100 /zigman2/quotes/210598364/realtime NDX -0.73% , up almost 11%, as of Friday’s close.

Growth stocks, companies whose earnings and revenues grow more quickly than their peers, have solidly outperformed value stocks, those seen as undervalued relative to their peers based on metrics like price to earnings or price to book value, over the last decade. That outperformance accelerated as the pandemic took hold.

Value stocks, however, have outperformed growth since the fall began and has continued to do so in November. The Russell 1000 Value Index /zigman2/quotes/210598148/delayed RLV -0.96% was up around 14.8% in the month to date, outpacing a rise of more than 9% for the Russell 1000 Growth Index /zigman2/quotes/210598136/delayed RLG -0.52% .

Growth stocks had seen their valuations relative to value stocks stretch sharply over the course of the 2020 rally, leaving ample room to snap back like a rubber band. For the year to date, the value index remains down 2%, while the growth gauge is up more than 30%.

The strong market gains and the rotation have been accompanied by what many market watchers see as other signs of excess, including a robust market for initial public offerings and a sudden rush of controversial SPAC, or special purpose acquisition company, listings, not to mention bitcoin’s /zigman2/quotes/31322028/realtime BTCUSD -0.34% attempt at taking out its 2017 record high.

The fuel has come from a spate of positive reports on COVID-19 vaccines from late-stage trials, while some also attribute the past week’s gains to enthusiasm over President-elect Joe Biden’s selection of former Federal Reserve Chairwoman Janet Yellen to serve as his Treasury secretary.

“The combination of a Treasury secretary that markets believe will help economic recovery, a Fed that will underwrite the whole thing by allowing the economy to run hot and inflation to overshoot before they tighten, and a handful of very promising COVID-19 vaccines set to arrive in weeks, has sent risk sentiment into overdrive,” said Kit Juckes, global macro strategist at Société Générale, in a Nov. 25 note.

/zigman2/quotes/210598065/realtime
US : Dow Jones Global
30,814.26
-177.26 -0.57%
Volume: 440.02M
Jan. 15, 2021 5:18p
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
3,768.25
-27.29 -0.72%
Volume: 2.74B
Jan. 15, 2021 5:18p
loading...
/zigman2/quotes/210598147/delayed
US : US Composite
2,123.20
-32.15 -1.49%
Volume: 2.03M
Jan. 15, 2021 4:30p
loading...
/zigman2/quotes/210598365/realtime
US : U.S.: Nasdaq
12,998.50
-114.14 -0.87%
Volume: 5.80M
Jan. 15, 2021 5:16p
loading...
/zigman2/quotes/210598364/realtime
US : U.S.: Nasdaq
12,803.93
-94.76 -0.73%
Volume: 708,796
Jan. 15, 2021 5:16p
loading...
/zigman2/quotes/210598148/delayed
US : US Composite
1,386.08
-13.47 -0.96%
Volume: 2.99M
Jan. 15, 2021 4:30p
loading...
/zigman2/quotes/210598136/delayed
US : US Composite
2,398.99
-12.60 -0.52%
Volume: 1.21M
Jan. 15, 2021 4:30p
loading...
/zigman2/quotes/31322028/realtime
US : CoinDesk
36,405.29
-125.06 -0.34%
Volume: 0.00
Jan. 18, 2021 9:43a
loading...
1 2
This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.